News

Intracoronary Abciximab Reduces Size of Large Myocardial Infarcts


 

FROM THE ANNUAL MEETING OF THE AMERICAN COLLEGE OF CARDIOLOGY

The INFUSE-AMI trial was published in JAMA (2012;307([7];doi:10.1001/jama.2012.421) at the same time the study results were presented at the ACC meeting.

INFUSE-AMI was sponsored by Atrium Medical with support from Medtronic and the Medicines Co. Dr. Stone reported having served as a consultant to those three companies and more than a dozen others.

Pages

Recommended Reading

Embolectomy May Help Despite Infarct Size
MDedge Cardiology
Infections, Pulmonary Complications Up Risk of Thrombotic Events
MDedge Cardiology
Cardiac Surgical Transfusions Linked to Infection Risk
MDedge Cardiology
IVC Filter Perforations Are Often Asymptomatic
MDedge Cardiology
CAS, CEA Evaluated for Contralateral Occlusion
MDedge Cardiology
Everlolimus-Eluting Coronary Stents Notch Major Thrombosis Victory
MDedge Cardiology
CoreValve Excels in 'Real-World' Study
MDedge Cardiology
Four Common Comorbidities Hike Risk of Late Post-TAVI Death
MDedge Cardiology
Prasugrel Bests Double-Dose Clopidogrel in Clopidogrel Nonresponders
MDedge Cardiology
Elective Angioplasty Safe at Hospitals Without Surgical Backup
MDedge Cardiology